These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3520575)
21. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice. Mayumi H; Good RA Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882 [TBL] [Abstract][Full Text] [Related]
22. Suppressor T cells in allogeneic bone marrow chimeras. Leshem B; Lebendiker Z; Weiss L; Slavin S; Kedar E Bone Marrow Transplant; 1987 Aug; 2(2):123-32. PubMed ID: 2901877 [TBL] [Abstract][Full Text] [Related]
23. Altered lymphocyte recognition repertoire during ageing. III. Changes in MHC restriction patterns in parental T lymphocytes and diminution in T suppressor function. Gorczynski RM; Kennedy M; MacRae S Immunology; 1984 Aug; 52(4):611-20. PubMed ID: 6235179 [TBL] [Abstract][Full Text] [Related]
25. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573 [TBL] [Abstract][Full Text] [Related]
26. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells. Ozawa H; Iwaguchi T; Kataoka T J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743 [TBL] [Abstract][Full Text] [Related]
27. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen. Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294 [TBL] [Abstract][Full Text] [Related]
28. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation. Weerasinghe A; Kawamura T; Moroda T; Seki S; Watanabe H; Abo T Cell Immunol; 1998 Apr; 185(1):14-29. PubMed ID: 9636679 [TBL] [Abstract][Full Text] [Related]
29. Growth of transplantable melanoma and leukaemia and prevention of virus-induced leukaemia in long lived radiation chimeras constructed with unmanipulated bone marrow. Pierpaoli W Clin Exp Immunol; 1985 Jan; 59(1):210-6. PubMed ID: 3882284 [TBL] [Abstract][Full Text] [Related]
31. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice. Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296 [TBL] [Abstract][Full Text] [Related]
32. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385 [TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning. Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556 [TBL] [Abstract][Full Text] [Related]
34. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras. Yoshikai Y; Ogimoto M; Matsuzaki G; Nomoto K J Immunol; 1990 Jul; 145(2):505-9. PubMed ID: 2114441 [TBL] [Abstract][Full Text] [Related]
35. Successful acceptance of adult liver allografts by intra-bone marrow-bone marrow transplantation. Okazaki S; Hisha H; Mizokami T; Takaki T; Wang X; Song C; Li Q; Kato J; Kamiyama Y; Ikehara S Stem Cells Dev; 2008 Aug; 17(4):629-39. PubMed ID: 18537462 [TBL] [Abstract][Full Text] [Related]
36. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants. Taniguchi K; Gondo H; Nomoto K J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626 [TBL] [Abstract][Full Text] [Related]
37. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow. Sado T; Kamisaku H; Kubo E J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789 [TBL] [Abstract][Full Text] [Related]
38. The fate of liver allografts in radiation bone marrow chimeras in mice. Nakamura T; Ikehara S; Inoue S; Oo MM; Hamashima Y Nihon Geka Hokan; 1985 Mar; 54(2):59-66. PubMed ID: 3899043 [No Abstract] [Full Text] [Related]
39. Enhancement of BM allografting from C57BL/6 'nude' mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6-->C3H/HeJ) and (C3H/HeJ-->C57BL/6) chimeras. Faktorowich Y; Lapidot T; Lubin I; Reisner Y Bone Marrow Transplant; 1993 Jul; 12(1):15-20. PubMed ID: 8374532 [TBL] [Abstract][Full Text] [Related]
40. Induction of transplantation tolerance in mice across major histocompatibility barrier by using allogeneic thymus transplantation and total lymphoid irradiation. Waer M; Palathumpat V; Sobis H; Vandeputte M J Immunol; 1990 Jul; 145(2):499-504. PubMed ID: 2142180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]